Fangda represented China International Capital Corporation (CICC) as sole sponsor and lead underwriter in the IPO and listing of China Resources Microelectronics (CRM) on the SSE STAR Market (Shanghai Stock Exchange Science and Technology Innovation Board) on February 27, 2020, raising approximately RMB3.8 billion (RMB 4.3 billion from the Full Exercise of the Over-Allotman Option). CRM is a semiconductor company incorporated in the Cayman Islands and with its principal business operation in the PRC. CRM is China’s first red-chip to list on the A-share market, paving way for other overseas-listed red-chip companies to return to the home market.
Fangda advises CICC on the first red-chip listing on the SSE STAR Market
2020 / 04 / 28
READ MORE
2026 / 11 / 09
Fangda Wins Final Victory for Client in PRC Court Proceedings Spanning Four Years over Jurisdiction Challenge, in Parallel with 197 Singapore International Commercial Arbitration Cases
2026 / 11 / 06
Fangda Advises Qyuns Therapeutics on Exclusive License Agreement with Caldera Therapeutics for TL1A/IL-17 Bispecific Antibody Program
2026 / 11 / 05
Fangda Advises Hinova Pharmaceuticals on Exclusive License Agreement with Evommune for VAV1 Molecular Glue Degrader EVO570
2026 / 11 / 04
Fangda Advises Minghui Pharmaceutical on Exclusive License Agreement with ASKA for MHB018A in Japan
2026 / 10 / 13
Fangda Assists Biren Technology on its Second H-share Placement



